cropped-logo.png

RegenSight

We are the TECH Company

  • Company
      • About Us
      • Team
      • Resources & Opportunities
      • Research Award
  • Science & Technology
      • Technologies
      • Projects
      • Clinical Trials
      • Visual Disorder
      • Publications and Presentations
  • Products
      • Devices for the CXL
        • C4V CHROMO4VIS
        • RitSight
        • DoRSight
      • Medical Professionals
      • Partnership
  • Granting & Investing
      • Public Granting
      • Investing
  • News & Media
  • Contacts
  • English
    • Italiano

Home

Monthly Archives: December 2022

JBIO_202270025_IC.indd
December 29, 2022
by Marco Lombardo News

Scientific publication on theranostic-guided corneal cross-linking on the cover of Journal of Biophotonics

Pleased to end this amazing year with the honor to see our most recent publication on theranostics on the cover of Journal of Biophotonics. The article is open access and available at https://onlinelibrary.wiley.com/doi/10.1002/jbio.202200218. Theranost ...

Leggi di più
Premio 1
December 23, 2022
by Marco Lombardo News

The Mario Lombardo Research Prize has been awarded to a young ophthalmologist

The Mario Lombardo award has been assigned to Dr. Raffaella Gioia, a young ophthalmologist recently specialized at the Magna Graecia University of Catanzaro. The celebration was held at the Regensight Research & Development Lab. in Reggio C ...

Leggi di più
Premio 2022
December 15, 2022
by Marco Lombardo News

The first “Mario Lombardo” Research Award goes to Dr. Raffaella Gioia

We are pleased to award the "Mario Lombardo" Research Prize to Dr. Raffaella Gioia, who ha been recently specialized in Ophthalmology at the Magna Graecia University of Catanzaro. We at Regensight award the commitment of Raffaella to the study and mana ...

Leggi di più

Search

Recent Posts

  • A Thousand Steps Toward a Clearer World with Theranostics
  • C4V CHROMO4VIS receives CE Certification under MDR: A historic milestone for Precision Medicine in Ophthalmology
  • Regensight is sponsor of the World Keratoconus Congress 2025
  • RitSight has been issued the MDR CE Certification
  • The Teracor project for the correction of visual disorders with theranostics is moving forward quickly

Recent Comments

    Archives

    • August 2025
    • May 2025
    • March 2025
    • January 2025
    • September 2024
    • July 2024
    • June 2024
    • April 2024
    • February 2024
    • November 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • January 2023
    • December 2022
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • January 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021

    Categories

    • BUSINESS
    • News
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Research Award

    Mario Lombardo

    To a young researcher committed to the study of keratoconus

    Apply
    cropped-logo.png

    The TECH Company

    Regensight develops and markets theranostic ophthalmic medical devices to improve vision and quality of life.

    Info
    Regensight srl is certified under UNI CEI EN ISO 13485:2021. Notified Body: TÜV Rheinland Italia.

    Information notice pursuant to Article 13 of EU Regulation 2016/679.

    Links
    • Home
    • Products
    • Contacts
    • News & Media
    • Privacy Policy
    • Cookies Policy
    Notes

    The information on this website is solely for healthcare professionals and is not promotional. By continuing, the user confirms they are a medical professional.

    Sign Up

    Keep me up to date with content, updates, and offers from Phlox

    "MailChimp" Plugin is Not Activated! In order to use this element, you need to install and activate this plugin.
    © 2025. Regensight | Creative web design by Arkomedia Web Agency
    Shopping Basket